116 related articles for article (PubMed ID: 11251824)
41. Advanced glycation endproducts in food and their effects on health.
Poulsen MW; Hedegaard RV; Andersen JM; de Courten B; Bügel S; Nielsen J; Skibsted LH; Dragsted LO
Food Chem Toxicol; 2013 Oct; 60():10-37. PubMed ID: 23867544
[TBL] [Abstract][Full Text] [Related]
42. The Maillard reaction and food allergies: is there a link?
Toda M; Heilmann M; Ilchmann A; Vieths S
Clin Chem Lab Med; 2014 Jan; 52(1):61-7. PubMed ID: 23492561
[TBL] [Abstract][Full Text] [Related]
43. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
[TBL] [Abstract][Full Text] [Related]
44. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
Nawale RB; Mourya VK; Bhise SB
Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
[TBL] [Abstract][Full Text] [Related]
45. Cloning, post-translational modifications, heterologous expression and ligand-binding of boar salivary lipocalin.
Loebel D; Scaloni A; Paolini S; Fini C; Ferrara L; Breer H; Pelosi P
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):369-79. PubMed ID: 10947950
[TBL] [Abstract][Full Text] [Related]
46. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
[TBL] [Abstract][Full Text] [Related]
47. Bio-physical characterization of ribose induced glycation: a mechanistic study on DNA perturbations.
Akhter F; Salman Khan M; Shahab U; Moinuddin ; Ahmad S
Int J Biol Macromol; 2013 Jul; 58():206-10. PubMed ID: 23524157
[TBL] [Abstract][Full Text] [Related]
48. Qualitative determination of specific protein glycation products by matrix-assisted laser desorption/ionization mass spectrometry Peptide mapping.
Humeny A; Kislinger T; Becker CM; Pischetsrieder M
J Agric Food Chem; 2002 Mar; 50(7):2153-60. PubMed ID: 11902972
[TBL] [Abstract][Full Text] [Related]
49. Post-translational non-enzymatic modification of proteins. II. Separation of selected protein species after glycation and other carbonyl-mediated modifications.
Miksík I; Deyl Z
J Chromatogr B Biomed Sci Appl; 1997 Oct; 699(1-2):311-45. PubMed ID: 9392381
[TBL] [Abstract][Full Text] [Related]
50. Substituted benzenediol Schiff bases as promising new anti-glycation agents.
Choudhary MI; Abbas G; Ali S; Shuja S; Khalid N; Khan KM; Atta-ur-Rahman ; Basha FZ
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):98-103. PubMed ID: 20583858
[TBL] [Abstract][Full Text] [Related]
51. Characterization of site-specific glycation during process development of a human therapeutic monoclonal antibody.
Miller AK; Hambly DM; Kerwin BA; Treuheit MJ; Gadgil HS
J Pharm Sci; 2011 Jul; 100(7):2543-50. PubMed ID: 21287557
[TBL] [Abstract][Full Text] [Related]
52. Enzyme activity and AGE formation in a model of AST glycoxidation by D-fructose in vitro.
Bousova I; Vukasović D; Juretić D; Palicka V; Drsata J
Acta Pharm; 2005 Mar; 55(1):107-14. PubMed ID: 15907228
[TBL] [Abstract][Full Text] [Related]
53. Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.
Khalifah RG; Baynes JW; Hudson BG
Biochem Biophys Res Commun; 1999 Apr; 257(2):251-8. PubMed ID: 10198198
[TBL] [Abstract][Full Text] [Related]
54. Antiglycation therapy: Discovery of promising antiglycation agents for the management of diabetic complications.
Abbas G; Al-Harrasi AS; Hussain H; Hussain J; Rashid R; Choudhary MI
Pharm Biol; 2016; 54(2):198-206. PubMed ID: 25853955
[TBL] [Abstract][Full Text] [Related]
55. Identification of a protein glycosylation operon from Campylobacter jejuni JCM 2013 and its heterologous expression in Escherichia coli.
Srichaisupakit A; Ohashi T; Fujiyama K
J Biosci Bioeng; 2014 Sep; 118(3):256-62. PubMed ID: 24650731
[TBL] [Abstract][Full Text] [Related]
56. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli.
Wilton R; Yousef MA; Saxena P; Szpunar M; Stevens FJ
Protein Expr Purif; 2006 May; 47(1):25-35. PubMed ID: 16510295
[TBL] [Abstract][Full Text] [Related]
57. epsilon-Glycation, APP and Abeta in ageing and Alzheimer disease: a hypothesis.
Schmitt HP
Med Hypotheses; 2006; 66(5):898-906. PubMed ID: 16442744
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of an olive leaf extract as a natural source of antiglycative compounds.
Navarro M; Morales FJ
Food Res Int; 2017 Feb; 92():56-63. PubMed ID: 28290298
[TBL] [Abstract][Full Text] [Related]
59. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
60. Intact glycation end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide.
Yamada H; Sasaki T; Niwa S; Oishi T; Murata M; Kawakami T; Aimoto S
Bioorg Med Chem Lett; 2004 Nov; 14(22):5677-80. PubMed ID: 15482946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
